Mindfulness Meditation Interventions for Long COVID: Biobehavioral Gene Expression and Neuroimmune Functioning.
Porter, Nicole, Jason, Leonard A · Neuropsychiatric disease and treatment · 2022 · DOI
Quick Summary
This review examines whether mindfulness meditation—a practice involving focused attention and relaxation—might help people with Long COVID and ME/CFS. The authors looked at existing research showing that meditation can reduce fatigue and sleep problems, and may help calm inflammation in the body after viral infections. They suggest that meditation could be a helpful tool to manage symptoms and potentially address some of the underlying biological problems in these conditions.
Why It Matters
This review is important because it explores a potential non-pharmacological intervention for ME/CFS and Long COVID, conditions with limited approved treatments. Understanding whether meditation might address both symptoms and underlying immune dysfunction could offer patients an accessible, low-cost complementary strategy. The focus on potential mechanisms—rather than just symptom relief—helps researchers think about how behavioral interventions might interact with the biological abnormalities seen in these conditions.
Observed Findings
Meditation has been found to reduce fatigue in various patient populations
Meditation has been associated with improvements in unrefreshing sleep
Studies in post-viral infection populations show meditation can enhance immune function
Meditation appears to reduce inflammatory-driven pathogenic processes in post-viral conditions
The literature suggests both symptomatic and potential biological pathway effects from meditation practice
Inferred Conclusions
Mindfulness meditation may be a viable treatment approach for managing symptoms in Long COVID and ME/CFS
Meditation may produce sustainable outcomes by addressing both symptomatology and underlying neuroimmune pathology
Alternative medical interventions like meditation warrant further investigation as part of multi-faceted treatment strategies for post-viral fatigue conditions
The biobehavioral and immune-modulating properties of meditation suggest mechanisms that could be relevant to post-viral infection pathophysiology
Remaining Questions
What is the quality and size of the evidence base specifically for meditation in ME/CFS versus Long COVID populations?
What This Study Does Not Prove
This is a literature review, not a new clinical trial, so it does not prove that meditation actually works for ME/CFS patients through rigorous experimental evidence. The review cannot establish whether improvements are due to meditation itself or to placebo effects, regression to the mean, or other factors. The authors do not present their own data showing that meditation changes gene expression or immune markers in ME/CFS populations specifically.
Which specific meditation practices (if any) are most effective, and what are optimal duration and frequency for treatment?
How do the effects of meditation compare to other evidence-based interventions for these conditions?
What are the mechanisms by which meditation might influence the specific neuroimmune abnormalities documented in ME/CFS (post-exertional malaise, microclot formation, mitochondrial dysfunction, etc.)?